Cyteir Therapeutics Price on December 2, 2024

CYTDelisted Stock  USD 2.76  0.01  0.36%   
If you're considering investing in Cyteir Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cyteir Therapeutics stands at 2.76, as last reported on the 10th of December, with the highest price reaching 2.81 and the lowest price hitting 2.75 during the day. We have found thirty technical indicators for Cyteir Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Cyteir Therapeutics' Mean Deviation of 2.76, downside deviation of 3.55, and Risk Adjusted Performance of 0.0842 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Cyteir Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CYT
Based on monthly moving average Cyteir Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cyteir Therapeutics by adding Cyteir Therapeutics to a well-diversified portfolio.

Related Headline

Prelude Therapeutics Headline on 2nd of December 2024

Morgan Stanley Downgrades Prelude Therapeutics MSN

Cyteir Therapeutics Valuation on December 2, 2024

It is possible to determine the worth of Cyteir Therapeutics on a given historical date. On December 2, 2024 Cyteir was worth 2.75 at the beginning of the trading date compared to the closed value of 2.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cyteir Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cyteir Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cyteir Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cyteir Therapeutics' related companies.
 Open High Low Close Volume
12/10/2024
  2.75    2.81    2.75    2.76    0.00  
Backtest Cyteir Therapeutics  |  Cyteir Therapeutics History  |  Cyteir Therapeutics Valuation 
Open Value
2.75
2.76
Closing Value
2.75
Upside

Cyteir Therapeutics Trading Date Momentum on December 2, 2024

Cyteir Therapeutics Fundamentals Correlations and Trends

By evaluating Cyteir Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cyteir Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cyteir financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cyteir Therapeutics Stock history

Cyteir Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cyteir is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cyteir Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cyteir Therapeutics stock prices may prove useful in developing a viable investing in Cyteir Therapeutics
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. The company was incorporated in 2012 and is based in Lexington, Massachusetts. Cyteir Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Cyteir Therapeutics Stock Technical Analysis

Cyteir Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Cyteir Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cyteir Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cyteir Therapeutics Period Price Range

Low
December 10, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Cyteir Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Cyteir Therapeutics December 10, 2024 Market Strength

Market strength indicators help investors to evaluate how Cyteir Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cyteir Therapeutics shares will generate the highest return on investment. By undertsting and applying Cyteir Therapeutics stock market strength indicators, traders can identify Cyteir Therapeutics entry and exit signals to maximize returns

Cyteir Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cyteir Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cyteir Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cyteir to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in Cyteir Stock

If you are still planning to invest in Cyteir Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyteir Therapeutics' history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.